Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
ACTIVE_NOT_RECRUITING
Status
Conditions
- Acute Lymphoblastic Leukemia
- Adult B Lymphoblastic Lymphoma
- Ann Arbor Stage I B Lymphoblastic Lymphoma
- Ann Arbor Stage II B Lymphoblastic Lymphoma
- Childhood B Acute Lymphoblastic Leukemia
- Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
- Childhood B Lymphoblastic Lymphoma
- Down Syndrome
- Hypodiploid B Acute Lymphoblastic Leukemia
- Philadelphia Chromosome Positive
Interventions
- DRUG: Cyclophosphamide
- DRUG: Cytarabine
- DRUG: Dexamethasone
- DRUG: Doxorubicin Hydrochloride
- OTHER: Laboratory Biomarker Analysis
- DRUG: Leucovorin Calcium
- DRUG: Mercaptopurine
- DRUG: Methotrexate
- DRUG: Pegaspargase
- OTHER: Quality-of-Life Assessment
- OTHER: Questionnaire Administration
- DRUG: Thioguanine
- DRUG: Vincristine Sulfate
Sponsor
Children's Oncology Group
Collaborators